Judith Fradkin - Concepedia

Author

Judith Fradkin

National Institute of Diabetes and Digestive and Kidney Diseases

Also Known As

A. Montosa, B. Gulanski, E. Magenheimer, HB Burch, J. E. Fradkin, J. Fradkin, JUDITH E. FRADKIN, JUDITH FRADKIN, Judith E Fradkin, Judith E. Fradkin

102

Publications

11.5K

Citations

H-Index

Concepts

All Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Massachusetts General Hospital Harvard University George Washington University

About

Judith Fradkin is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in medicine, diabetes, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	2.3K
2	Public Health	12	12	1.8K
3	Biochemistry	2	2	61
4	Health Sciences	1	1	44
5	Cellular Physiology	1	1	17

Judith Fradkin

Publications

9.1K

Citations

H-Index

Page 1

	Year	Citations
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Melanie J. Davies, David A. D’Alessio, Judith Fradkin, Diabetes Care	2018	3.4K
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Melanie J. Davies, David A. D’Alessio, Judith Fradkin, Diabetologia American Diabetes AssociationMetabolic SyndromeDiabetes ManagementDiabetes EpidemiologyHealth Policy	2018	1.4K
The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988–2010 Sarah Stark Casagrande, Judith Fradkin, Sharon Saydah, Diabetes Care	2013	713
Prevalence of Diabetes and High Risk for Diabetes Using A1C Criteria in the U.S. Population in 1988–2006 Catherine C. Cowie, Keith Rust, Danita D. Byrd-Holt, Diabetes Care	2010	686
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial Valery T. Miller, John C. LaRosa, Vanessa M. Barnabei, JAMA	1995	605
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus Peter Libby, David M. Nathan, Kristin Abraham, Circulation Metabolic SyndromeType 1Diabetes ManagementNational HeartDiabetes Epidemiology	2005	266
Creutzfeldt-Jakob Disease in Pituitary Growth Hormone Recipients in the United States Judith Fradkin JAMA Clinical DisordersTranslational MedicinePituitary GlandGrowth HormoneCreutzfeldt-jakob Disease	1991	151
Diabetes Performance Measures: Current Status and Future Directions Patrick J. O’Connor, Noni L. Bodkin, Judith Fradkin, Diabetes Care	2011	136
Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study David M. Nathan, William C. Knowler, Sharon L. Edelstein, Diabetes Care	2019	121
Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients James L. Mills, Lawrence B. Schonberger, Diane K. Wysowski, The Journal of Pediatrics Pituitary GlandGrowth HormoneHealth PolicyHuman GrowthLong-term Mortality	2004	119

Page 1